Voquezna denied for missing prior authorization by UnitedHealthcare?

UnitedHealthcare's specific coverage criteria for voquezna are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why UnitedHealthcare Requires Prior Authorization for Voquezna

Voquezna (vonoprazan) is a newer potassium-competitive acid blocker. UnitedHealthcare, like most large insurers, places newer branded medications on a tier requiring prior authorization (PA) before it will pay a claim. A PA denial means the prescription was dispensed or submitted without an approved PA on file — or that a PA was requested and UHC determined you have not yet met its coverage criteria.

## Why This Denial Is Appealable

A prior-authorization denial is not a final answer. It is a coverage determination that must go through the same full appeals process as any other adverse benefit decision:

• Internal appeal (Level 1 and, if offered, Level 2): You or your prescriber can appeal directly to UHC. Request that a physician reviewer — not just a nurse reviewer — evaluate the case.
• ACA §2719 external review: If the internal appeal is denied, you may request independent external review. The external reviewer has no financial relationship with UHC and issues a binding decision. The window to file is typically about four months from the internal denial — calendar this date immediately.
• ERISA §503 (employer plans): Requires UHC to provide all clinical criteria and the specific rationale used, so you can address every gap in your appeal.
• Expedited track: If waiting for a standard decision would seriously jeopardize your health, request expedited PA appeal and external review simultaneously.

## Documentation to Gather

• UHC's PA criteria: Call UHC or download its published coverage policy for Voquezna/PCABs. List every criterion UHC requires and confirm your records address each one.
• Prescriber medical-necessity letter: Your physician should explain the diagnosis, why a PCAB is appropriate, the clinical severity, and why Voquezna specifically was chosen. The letter should map directly to UHC's stated criteria.
• Prior treatment history: A dated list of every medication tried before Voquezna — name, dose range, duration, and reason for discontinuation or inadequate response. This is especially important if UHC's policy requires a trial of a proton pump inhibitor (PPI) first.
• Diagnostic records: Endoscopy reports, pH monitoring, or other objective studies confirming the diagnosis and its severity.

## Criteria-Mapping Approach

Obtain the exact text of UHC's PA policy (ask for it in writing if not publicly posted). Then draft a response that addresses every bullet point:

| UHC PA requirement | Supporting documentation | |---|---| | Confirmed diagnosis of [condition] | Office note dated [X] with ICD-10 code | | Trial and failure of prior therapy | Medication history with dates and outcomes | | Prescriber specialty / attestation | Prescriber letter on letterhead |

Do not leave any criterion unaddressed — an unanswered criterion is the most common reason second-level appeals also fail.

## Next Step

If your prescriber's office has not already submitted a PA, do that first — an initial PA determination is faster than an appeal. If PA was already denied, file the written internal appeal promptly, attach all documentation, and calendar the external-review deadline shown on your denial letter.